Docking studies on the interaction of flavonoids with fat mass and obesity associated protein

Pakistan Journal of Pharmaceutical Sciences

Volumn 28, Issue 5, 2015, Pages 1647-1653

  Mohammed, Alamri ^a   Al Numair, Khalid Suliman ^b   Balakrishnan, Aristatile ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Anti obesity effects; Molecular docking; Orlistat; Quercetin

Indexed keywords

DAIDZEIN; EXEMESTANE; FLAVONOID; KAEMPFEROL; LETROZOLE; OBESITY ASSOCIATED PROTEIN; PROTEIN; QUERCETIN; RUTOSIDE; TETRAHYDROLIPSTATIN; UNCLASSIFIED DRUG; FTO PROTEIN, HUMAN; LACTONE;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG PROTEIN BINDING; FAT MASS; MOLECULAR DOCKING; MOLECULAR DYNAMICS; OBESITY; ADIPOSE TISSUE; CHEMISTRY; HUMAN; METABOLISM;

ADIPOSE TISSUE; FLAVONOIDS; HUMANS; LACTONES; MOLECULAR DOCKING SIMULATION; PROTEINS;

EID: 84940670996     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Berman HM, Westbrook J and Feng Z (2000). The protein data bank. Nucleic Acids Res., 28:235-242.
2. Cao Y (2007). Angiogenesis modulates adipogenesis and obesity. J. Clin. Invest., 117:2362-2368.
3. Cao Y (2010). Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat. Rev. Drug Discov., 9:107-115.
4. Chien PJ, Chen YC and Lu SC (2005). Dietary Flavonoids Suppress Adipogenesis in 3T3-L1 Preadipocytes. J. Food Drug Anal., 13:168-175.
5. Church C, Lee S and Bagg EA (2009). A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene. PLoS Genetics. 5(8):e1000599.
6. Cook NC and Samman S (1996). Flavonoids-chemistry, metabolism, cardioprotective effects and dietary resources. J. Nutr. Biochem., 7:66-76.
7. Dell'Agli M and Bosisio E (2002). Biflavones of ginkgo biloba stimulate lipolysis in 3T3-L1 adipocytes. Planta Medica. 68:76-79.
8. Dina C, Meyre D and Gallina S (2007). Variation in FTO contributes to childhood obesity and severe adult obesity. Nat. Genet., 39:724-726.
9. Fischer J, Koch L and Emmerling C (2009). Inactivation of the Fto gene protects from obesity. Nature, 458:894-898.
10. Frayling TM, Timpson NJ and Weedon MN (2007). A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Sci., 316:889-894.
11. Grove KA and Lambert JD (2010). Laboratory, epidemiological and human intervention studies show that tea (Camellia sinensis) may be useful in the prevention of obesity. J. Nutr., 140:446-453.
12. Harmon AW and Harp JB (2001). Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis. Am. J. Physiol. Cell Physiol., 280:C807-C813.
13. Harmon AW, Patel YM and Harp JB (2002). Genistein inhibits CCAAT/enhancer-binding protein beta (C/EBPβ) activity and 3T3-L1 adipogenesis by increasing C/EBP homologous protein expression. J. Biochem., 367:203-208.
14. Hasegawa N (2000). Inhibition of lipogenesis by pycnogenol. Phytother. Res., 14:472-473.
15. Havsteen BH (2002). The biochemistry and medical significance of the flavonoids. Pharmacol. Ther., 96:67-202.
16. Kang NS, Chae CH and Yoo SE (2006). Study on the hydrolysis mechanism of phosphodiesterase 4 using molecular dynamics simulations. Molecular Simulation, 32:369-374.
17. Kuppusamy UR and Das NP (1992). Effects of flavonoids on cyclic AMP phosphodiesterase and lipid mobilization in rat adipocytes. Biochem. Pharmacol., 44:1307-1315.
18. Kuppusamy UR and Das NP (1994). Potentiation of betaadrenoceptor agonist-mediated lipolysis by quercetin and fisetin in isolated rat adipocytes. Biochemical. Pharmacology, 47:521-519.
19. Kwon O, Eck P and Chen S (2007). Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. FASEB J, 21:366-377.
20. Masoodi TA and Alhamdan A (2010). Inhibitory effect of flavonoids on mutant H-Rasp protein. Bioinformation, 5:11-15.
21. Middleton E and Kandaswami C (1986). The impact of plant flavonoids on mammalian biology: Implications for immunity, inflammation and cancer. In the Flavonoids Advances in Research since. Harborme JB edn. Chapman and Hall, London, pp. 619-652.
22. Mine Y (2001). Molecular dynamic simulation of model lipid membranes: Structural effects of impurities. Mol. Simul., 27:187-197.
23. Morris GM, Goodsell DS and Halliday RS (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem., 19:1639-1662.
24. Murase T, Nagasawa A and Suzuki J (2002). Beneficial effects of tea catechins on diet-induced obesity: Stimulation of lipid catabolism in the liver. Int. J. Obes. Relat. Metab. Disord., 26:1459-1464.
25. Packer L, Rimbach G and Virgili F (1999). Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol. Free Radic. Biol. Med., 27:704-724.
26. Peluso MR (2006). Flavonoids attenuate cardiovascular disease, inhibit phosphodiesterase and modulate lipid homeostasis in adipose tissue and liver. Exp. Biol. Med., 231:1287-1299.
27. Rayalam S, Della-Fera MA and Baile CA (2008). Phytochemicals and regulation of the adipocyte life cycle. J. Nutr. Biochem., 19:717-726.
28. Ryuichiro I, Tohru T and Kentaro S (2008). Refinement of comparative models of protein structure by using multicanonical molecular dynamic simulation. Mol. Simul., 34:327-336.
29. Shisheva A and Shechter Y (1992). Quercetin selectively inhibits insulin receptor function in vitro and the bioresponses of insulin and insulinomimetic agents in rat adipocytes. Biochemistry, 31:8059-8063.
30. Takashi N, Hiromi T and Yoshimichi H (2008). Interaction between a twelve-residue segment of antifreeze protein type I, or its mutants and water molecules. Mol. Simul., 34:309-325.
31. Tsuda T (2008). Regulation of adipocyte function by anthocyanins; Possibility of preventing the metabolic syndrome. J. Agric. Food Chem., 56:642-646.
32. Van Beek TA (2002). Chemical analysis of ginkgo biloba leaves and extracts. J. Chromatogr., 967:21-55.
33. Wishart DS, Knox C and Guo AC (2006). Drug Bank: A comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res., 34:D668-D672.